UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: A | B | C | D | F | G | H | J | K | L | M | N | O | P | R | W
Number of items: 50.

A

Abbasi, AM and Chester, KA and Talbot, IC and Macpherson, AS and Boxer, G and Forbes, A and Malcolm, ADB and Begent, RHJ (1993) CD44 is associated with proliferation in normal and neoplastic human colorectal epitheial-cells. European Journal of Cancer , 29A (14) 1995 - 2002.

Adair, JR and Antoniw, P and Baldock, D and Begent, R and Boden, J and Boden, R and Finney, H and Gill, BS and King, DJ and Lawson, ADG and Lyons, A and Mountain, A and Owens, RJ and Pedley, RB and Rolfe, M and Turner, AYGT (1993) Development of a humanised anti-tumour agent from the monoclonal antibody A5B7 directed against carcinoembrionic antigen. In: Antib. Immunoconjug. Radiopharm. (pp. 77 - ?).

ALLEN, DG and BAAK, J and BELPOMME, D and BEREK, JS and BERTELSEN, K and HUININK, WWT and VANDERBURG, MEL and CALVERT, AH and CONTE, PE and DAUPLAT, J and EISENHAUER, EA and FAVALLI, G and HACKER, NF and HAMILTON, TC and HANSEN, HH and HANSEN, M and VANHOUWELINGEN, HC and KAYE, SB and LEVIN, L and LUND, B and NEIJT, JP and OZOLS, RF and PICCART, MJ and RUSTIN, GJS and SESSA, C and SOUTTER, WP and THIGPEN, JT and TROPE, C and VERMORKEN, JB and DEVRIES, EGE (1993) ADVANCED EPITHELIAL OVARIAN-CANCER - 1993 CONSENSUS STATEMENTS. ANN ONCOL , 4 83 - 88.

Angal, S and King, DJ and Bodmer, MW and Turner, A and Lawson, ADG and Roberts, G and Pedley, BAA and J, R (1993) A single amino acid substitution abolishes the heterogeneity of chimeric mouse/human (IgG4) antibody. Molecular Immunology , 30 105 - 108.

B

BEGENT, RHJ and CHESTER, KA and CONNORS, T and CROWTHER, D and FOX, B and GRIFFITHS, E and HINCE, TA and LEDERMANN, JA and MCVIE, JG and MINOR, P and SECHER, DS and SCHWARTSMANN, G and THORPE, R and WILBIN, C and ZWIERZINA, H (1993) CANCER-RESEARCH CAMPAIGN OPERATION MANUAL FOR CONTROL RECOMMENDATIONS FOR PRODUCTS DERIVED FROM RECOMBINANT-DNA TECHNOLOGY PREPARED FOR INVESTIGATIONAL ADMINISTRATION TO PATIENTS WITH CANCER IN PHASE-I TRIALS. EUR J CANCER , 29A (13) 1907 - 1910.

Boxer, GM and Pedley, RB and Abbasi, AM and Casey, JLABRHJ (1993) Accessibility of CEA epitopes in colonic adenocarcinoma may influence antibody localisation. In: (Proceedings) Proceedings BACR, Br J. Cancer. (pp. 56 - ?).

C

CALVERT, AH and LIND, MJ and MILLWARD, MM and CANTWELL, BMJ and GUMBRELL, L and PROCTOR, M and SIMMONS, D and CHAPMAN, F and ROBINSON, A and CHARLTON, C and BALMANNO, K and NEWELL, D (1993) LONG-TERM ORAL ETOPOSIDE IN METASTATIC BREAST-CANCER - CLINICAL AND PHARMACOKINETIC RESULTS. CANCER TREAT REV , 19 27 - 33.

CALVERT, H and JUDSON, I and VANDERVIJGH, WJF (1993) PLATINUM COMPLEXES IN CANCER MEDICINE - PHARMACOKINETICS AND PHARMACODYNAMICS IN RELATION TO TOXICITY AND THERAPEUTIC ACTIVITY. CANCER SURV , 17 189 - 217.

CAYEUX, SJ and BEVERLEY, PCL and SCHULZ, R and DORKEN, B (1993) ELEVATED PLASMA PROSTAGLANDIN E(2) LEVELS FOUND IN 14 PATIENTS UNDERGOING AUTOLOGOUS BONE-MARROW OR STEM-CELL TRANSPLANTATION. BONE MARROW TRANSPL , 12 (6) 603 - 608.

Chester, KA and Robson, L and Hawkins, RE and Keep, PA and Pedley, RB and Boden, JAABRHJ (1993) Production, characterisation and genetic manipulation of bacterial (anti-CEA) Fab'. In: (Proceedings) Proceedings BACR, Br J Cancer. (pp. 13 - ?).

CHIANELLI, M and SIGNORE, A and HICKS, R and TESTI, R and NEGRI, M and BEVERLEY, PCL (1993) A SIMPLE METHOD FOR THE EVALUATION OF RECEPTOR-BINDING CAPACITY OF MODIFIED CYTOKINES. J IMMUNOL METHODS , 166 (2) 177 - 182.

Cooper, DP and Lee, SM and Margison, GP and O'Connor, PJ and Thatcher, N and Crowther, D (1993) Relationship between 06-alkylguanine-DNA-alkyltransferase activity and 06-methyldeoxyguanosine formation after treatment with methylating agents in patients with malignant melanoma. In: Paterson Annual Research Report. (pp. 36 - ?).

D

Davis, CL and Rohatiner, AZS and Lim, J and Whelan, JS and Amess, J and Love, S and Stead, E and Lister, TA (1993) The management of recurrent acute myelogenous leukaemia at a single center over a fifteen year period. British Journal of Haematology , 83 404 - 411.

Dhaliwal, HS and Rohatiner, AZS and Gregory, W and Richards, MA and Johnson, PWM and Whelan, JS and Gallager, CJ and Matthews, J and Ganesan, TS and Barnett, MJ and Waxman, JH and Stansfeld, AG and Wrigley, PFM and Slevin, ML and Malpas, JS and Lister, TA (1993) Combination chemotherapy for intermediate and high grade non-Hodgkin's lymphoma. British Journal of Cancer , 68 767 - 774.

F

FISHER, TC and MILNER, AE and GREGORY, CD and JACKMAN, AL and AHERNE, GW and HARTLEY, JA and DIVE, C and HICKMAN, JA (1993) BCL-2 MODULATION OF APOPTOSIS INDUCED BY ANTICANCER DRUGS - RESISTANCE TO THYMIDYLATE STRESS IS INDEPENDENT OF CLASSICAL RESISTANCE PATHWAYS. CANCER RES , 53 (14) 3321 - 3326.

FISHWICK, D and LOUGHNEY, E and LIND, M and CALVERT, H and CORRIS, PA and GIBSON, GJ (1993) COMPARISON OF MYELOTOXICITY RELATING TO 2 CHEMOTHERAPY REGIMENS FOR SMALL-CELL LUNG-CANCER (SCLC). AM REV RESPIR DIS , 147 (4) A749 - A749.

FOSTER, BJ and NEWELL, DR and CARMICHAEL, J and HARRIS, AL and GUMBRELL, LA and JONES, M and GOODARD, PM and CALVERT, AH (1993) PRECLINICAL, PHASE-I AND PHARMACOKINETIC STUDIES WITH THE DIMETHYL PHENYLTRIAZENE-CB10-277. BRIT J CANCER , 67 (2) 362 - 368.

FOSTER, BJ and NEWELL, DR and GUMBRELL, LA and JENNS, KE and CALVERT, AH (1993) PHASE-I TRIAL WITH PHARMACOKINETICS OF CB10-277 GIVEN BY 24 HOURS CONTINUOUS INFUSION. BRIT J CANCER , 67 (2) 369 - 373.

G

GARBIRAS, BJ and WYATT, MD and WRIGHT, SR and LEE, M and FORROW, S and HARTLEY, JA (1993) DNA-BINDING STUDIES OF N-TO-C OLIGOMETHYLENE-LINKED ANALOGS OF DISTAMYCIN-A. ABSTR PAP AM CHEM S , 206 120 - MEDI.

Gerard, B and Aamdal, S and Lee, SM and Leyvraz, S and Lucas, C and D'Incalci, M and Bizzari, JP (1993) Activity and unexpected lung toxicity of the sequential administration of two alkylating agents-dacarbazine and fotemustine-in patients with melanoma. European Journal of Cancer , 29A (5) 711 - 719.

H

Harland, SJ and Cook, PA and Fossa, SD and Horwich, A and Parkinson, MC and Roberts, JT and Stenning, SP (1993) Risk factors for carcinoma-in-situ of the contralateral testis in patients with testicular cancer; an interim report. European Urology , 23 202 - 206.

HARTLEY, JA and SOUHAMI, RL and BERARDINI, MD (1993) ELECTROPHORETIC AND CHROMATOGRAPHIC-SEPARATION METHODS USED TO REVEAL INTERSTRAND CROSS-LINKING OF NUCLEIC-ACIDS. J CHROMATOGR-BIOMED , 618 (1-2) 277 - 288.

HARTLEY, JM and NICHOLSON, PW and ALLEN, R and LAMOND, P and HARLAND, SJ and SOUHAMI, RL (1993) PHARMACOKINETICS OF 10-ETHYL-10-DEAZA-AMINOPTERIN, EDATREXATE, GIVEN WEEKLY FOR NON-SMALL-CELL LUNG-CANCER. CANCER CHEMOTH PHARM , 31 (4) 328 - 332.

Hochhauser, D and Harris, AL (1993) The role of topoisomerase II alpha and beta in drug resistance. Cancer Treat Rev , 19 (2) 181 - 194.

HOCHHAUSER, D and HARRIS, AL (1993) THE ROLE OF TOPOISOMERASE-II-ALPHA AND TOPOISOMERASE-II-BETA IN DRUG-RESISTANCE. CANCER TREAT REV , 19 (2) 181 - 194.

J

JACKMAN, AL and BISSET, GMF and JODRELL, DI and GIBSON, W and KIMBELL, R and BAVETSIAS, V and CALVERT, AH and HARRAP, KR and STEPHENS, TC and SMITH, MN and BOYLE, FT (1993) GAMMA-LINKED DIPEPTIDE ANALOGS OF 2-DESAMINO-2-METHYL-N-10-PROPARGYL-5,8-DIDEAZAFOLATE AS ANTITUMOR AGENTS. CHEMISTRY AND BIOLOGY OF PTERIDINES AND FOLATES , 338 579 - 584.

Johnson, PWM and Whelan, JS and Longhurst, S and Stepniewska, K and Matthews, J and Amess, J and Norton, A and Rohatiner, AZS and Lister, TA (1993) B-2 microglobulin: a prognostic factor in diffuse aggressive non-Hodgkin's lymphomas. British Journal of Cancer , 67 792 - 797.

K

KELLY, K and PRITCHARD, J and GORDON, I and BEVERLEY, PCL and CHU, AC (1993) CD1 ANTIBODY IMMUNOLOCALIZATION IN LANGERHANS CELL HISTIOCYTOSIS. LANCET , 342 (8867) 367 - 368.

L

LEE, M and RHODES, AL and WYATT, MD and DINCALCI, M and FORROW, S and HARTLEY, JA (1993) INVITRO CYTOTOXICITY OF GC SEQUENCE DIRECTED ALKYLATING-AGENTS RELATED TO DISTAMYCIN. J MED CHEM , 36 (7) 863 - 870.

Lee, SM and Harris, M and Rennison, J and Crowther, D and McGown, A and Bromley, M and Elder, RH and Rafferty, JA and Margison, GP (1993) In situ expression of 06-methylguanine-DNA methyltransferase in ovarian and Hodgkin's tumours. In: (Proceedings) BACR/ACP/BOA Annual Meeting, Sheffield.. (pp. 80 - ?). British Journal of Cancer

Lee, SM and Harris, M and Rennison, J and McGown, A and Bromley, M and Elder, RH and Rafferty, JA and Crowther, D and Margison, GP (1993) Expression of 06-alkylguanine-DNA alkyltransferase in situ in ovarian and Hodgkin's Tumours. European Journal of Cancer , 29A (9) 1306 - 1312.

Lee, SM and Margison, GP and Woodcock, AA and Thatcher, N (1993) Sequential administration of varying doses of dacarbazine and fotemustine in advanced malignant melanoma. British Journal of Cancer , 67 (6) 1356 - 1360.

Lee, SM and O'Connor, P and Thatcher, N and Crowther, D and Margison, GP and Cooper, D (1993) Formation and loss of 06-methyldeoxyguanosine (06-MedG) in peripheral leukocytes of patients receiving dacarbazine (DTIC) or CB 10-277. In: (Proceedings) 1993 AACR Annual Meeting/84th Annual Meeting, Orlando, FL.. (pp. 355 - ?). Proc Am Assoc Cancer Res

Lee, SM and Thatcher, N and Crowther, D and Margison, GP (1993) Inactivation of 06-alkylguanine-DNA alkyltransferase in human blood mononuclear cells by temozolomide. In: (Proceedings) Association of Cancer Physicians 9th Annual Meeting, Birmingham, UK.. (pp. 60 - ?). British Journal of Cancer

Lee, SM and Thatcher, N and Dougal, M and Margison, and GP, (1993) Dosage and cycle effects of dacarbazine (DTIC) and fotemustine on 06-alkylguanine-DNA alkyltransferase in human peripheral blood mononuclear cells. British Journal of Cancer , 67 (2) 216 - 221.

M

MacCallum, PK and Davis, CL and Rohatiner, AZS and Lim, J and Gupta, RK and Whelan, JS and Price, CGA and Evans, M and Amess, J and Leahy, M and Johnson, PWM and Oza, AM and Lister, TA (1993) Mitoxantrone and cytosine arabinoside as treatment for acute myeloblastic leukaemia at first recurrence. Leukemia , 7 1496 - 1499.

Marshall, D and Pedley, RB and Boden, J and Boden, RABRHJ (1993) Improving radioimunotargeting using streptavidin for rapid clearance of circulating radiolabelled biotinylated antibodies-studies with tumour bearing mice. In: (Proceedings) Proceedings BACR, Br J Cancer. (pp. 70 - ?).

N

Newell, DR and Pearson, AD and Balmanno, K and Price, L and Wyllie, RA and Keir, M and Calvert, AH and Lewis, IJ and Pinkerton, CR and Stevens, MC (1993) Carboplatin pharmacokinetics in children: the development of a pediatric dosing formula. The United Kingdom Children's Cancer Study Group. J Clin Oncol , 11 (12) 2314 - 2323.

NEWELL, DR and PEARSON, ADJ and BALMANNO, K and PRICE, L and WYLLIE, RA and KEIR, M and CALVERT, AH and LEWIS, IJ and PINKERTON, CR and STEVENS, MCG (1993) CARBOPLATIN PHARMACOKINETICS IN CHILDREN - THE DEVELOPMENT OF A PEDIATRIC DOSING FORMULA. J CLIN ONCOL , 11 (12) 2314 - 2323.

O

O'Connor, PJ and Lee, SM and Cooper, DP and Thatcher, N and Rafferty, J and Fan, CY and Zaidi, SNHMGP (1993) Heterogeneity in the mechanisms of resistance to chemotherapy related to DNA damage and repair. In: D'Incalci, M and Mantovani, A and Garattini, S, (eds.) Heterogeneity of Cancer Cells. (89 - 103). Raven Press: New York.

P

PEDLEY, RB and BODEN, JA and BODEN, R and DALE, R and BEGENT, RHJ (1993) COMPARATIVE RADIOIMMUNOTHERAPY USING INTACT OF F(AB')2 FRAGMENTS OF I-131 ANTI-CEA ANTIBODY IN A COLONIC XENOGRAFT MODEL. BRIT J CANCER , 68 (1) 69 - 73.

Pigaditou, A and Rohatiner, AZ and Whelan, JS and Johnson, PW and Ganjoo, RK and Rossi, A and Norton, AJ and Amess, J and Lim, J and Lister, TA (1993) Fludarabine in low-grade lymphoma. Seminars in Oncology , 20 (5) 24 - 7.

PRETI, C and TROUTMAN, MV and LEE, M and FORROW, S and HARTLEY, JA (1993) DESIGN, SYNTHESIS, AND DNA-BINDING PROPERTIES OF C-TERMINUS TRUNCATED AND IMIDAZOLE-CONTAINING ANALOGS OF DISTAMYCIN. ABSTR PAP AM CHEM S , 206 121 - MEDI.

PUVVADA, MS and HARTLEY, JA and JENKINS, TC and THURSTON, DE (1993) A QUANTITATIVE ASSAY TO MEASURE THE RELATIVE DNA-BINDING AFFINITY OF PYRROLO[2,1-C][1,4]BENZODIAZEPINE (PBD) ANTITUMOR ANTIBIOTICS BASED ON THE INHIBITION OF RESTRICTION-ENDONUCLEASE BAMHI. NUCLEIC ACIDS RES , 21 (16) 3671 - 3675.
An open access publication

R

Rohatiner, AZS and Bassan, R and Battista, R and Whelan, JS and Johnson, PWM and Amess, JAL and Arnott, SJ and Burini, G and Personeni, A and Carter, M and Barbui, T and Lister, TA (1993) Myeloablative therapy with autologous bone marrow transplantation (ABMT) as consolidation of first remission in younger patients with acute myelogenous leukaemia (AML). In: American Society of Hematology, 35th Annual Meeting, Dec 1993.

Rohatiner, AZS and Johnson, PWM and Mahmoud, M and Arnott, SJ and Amess, JAL and Norton, AJ and Adams, K and Matthews, J and Whelan, JS and Lister, TA (1993) Myeloablative therapy with autologous bone marrow transplantation (ABMT) in low grade lymphoma. In: Keystone Symposium 1993.

W

Whelan, J (1993) Hypercalcaemia and adamantinoma (letter). Sarcoma , 3 197 - ?.
An open access publication

Whelan, JS and Ganjoo, R and Johnson, PWM and Rohatiner, AZS and Lister, TA (1993) Treatment of low grade non-Hodgkin's lymphomas with Fludarabine. Leukemia and Lymphoma , 10 (S1) 35 - 37.

Whelan, JS and Phear, G and Yamauchi, M and Meuth, M (1993) Clustered base substitutions in CTP synthetase conferring drug resistance in CHO cells. Nature Genetics , 3 317 - 321.

Whelan, JS and Radford, JA and Stansfeld, AG and Harris, M and Johnson, PWM and Matthews, J and Deakin, D and Rohatiner, AZS and Crowther, D and Lister, TA (1993) Intensive combination chemotherapy for diffuse low grade non-Hodgkin's lymphomas of B- and T-cell lineage. In: 5th International Conference on Malignant Lymphoma, June 1993.

This list was generated on Sat May 18 07:06:03 2013 BST.